89018 Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 

ANNUALIZED BURDEN HOUR TABLE

Forms (if necessary) Respondents (if necessary) Number of 

respondents 

Number of 

responses 

per 

respondents 

Average 

burden per 

response 

Total burden 

hours 

Project Abstract Summary ................ Grant applicants ............................... 3,467 1 1 3,467 

Total ........................................... ........................................................... 3,467 ........................ 1 3,467 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2024–26103 Filed 11–8–24; 8:45 am] 

BILLING CODE 4151–AE–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business-Anti-Infective Therapeutics. 

Date: December 4, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marcus Ferrone, Pharm.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–2371, marcus.ferrone@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 23–064 

P01 Review: Translational Research on 

Antiretrovirals and Methamphetamine in the 

CNS. 

Date: December 4, 2024. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Raul Rojas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

Bethesda, MD 20892, (301) 451–6319, rojasr@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Social and Community Influences 

Across the Lifecourse. 

Date: December 5, 2024. 

Time: 10:30 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kate Fothergill, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3142, 

Bethesda, MD 20892, 301–435–1782, 

fothergillke@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–23– 

213: Interactive Digital Media Biomedical 

Science Resources for Pre-College Students 

and Teachers. 

Date: December 6, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marie-Jose Belanger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 6188, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1267, belangerm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 5, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26111 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

General Medical Sciences Council. 

The meeting will be held as a virtual 

meeting and open to the public, as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance, such as sign language 

interpretation or other reasonable 

accommodations, should submit a 

request using the following link: https:// 

www.nigms.nih.gov/Pages/ 

ContactUs.aspx at least 5 days prior to 

the event. The open session will also be 

videocast, closed captioned, and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov). 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

General Medical Sciences Council. 

Date: February 6, 2025. 

Open: 9:30 a.m. to 12:30 p.m. 

Agenda: For the discussion of program 

policies and issues; opening remarks; report 

of the Director, NIGMS; and other business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Closed: 1:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 89019 

Contact Person: Erica L. Brown, Ph.D., 

Director, Division of Extramural Activities, 

National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 2AN24C, Bethesda, 

MD 20892, 301–594–4499, erica.brown@

nih.gov. 

Members of the public are welcome to 

provide written comments by emailing 

NIGMS_DEA_Mailbox@nigms.nih.gov at least 

3 days in advance of the meeting. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nigms.nih.gov/About/Council, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: November 5, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26074 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Acquired Immunodeficiency 

Syndrome Research Study Section Acquired 

Immunodeficiency Syndrome Research 

Study Section. 

Date: December 6, 2024. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3D32, 

Rockville, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Robert C. Unfer, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3D32, Rockville, MD 

20892, (240) 669–5035, robert.unfer@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 5, 2024 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26110 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; Data Use Certification for the 

NIH Brain Development Cohorts 

(NBDC), (National Institute on Drug 

Abuse) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The purpose of this revision 

is to clarify inclusion of the HBCD 

Study, to update data use terms and 

conditions, and to request a progress 

report statement at the time of renewal. 

Burden levels remain unchanged. 

In compliance with the requirement 

of the Paperwork Reduction Act of 1995 

to provide opportunity for public 

comment on proposed data collection 

projects, the National Institute on Drug 

Abuse (NIDA) will publish periodic 

summaries of proposed projects to be 

submitted to the Office of Management 

and Budget (OMB) for review and 

approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Dr. Elizabeth A. Hoffman, 

Associate Director, Division of 

Extramural Research, National Institute 

on Drug Abuse, 3WFN Room 09C75 

MSC 6021, Gaithersburg, MD 20877, or 

call non-toll-free number (301) 594– 

2265 or Email your request, including 

your address to: elizabeth.hoffman@

nih.gov. Formal requests for additional 

plans and instruments must be 

requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimizes 

the burden of the collection of 

information on those who are to 

respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Proposed Collection Title: Data Use 

Certification for the NIH BRAIN 

Development Cohorts (NBDC), (NIDA) 

0925–0780, exp., date 10/31/2026 

REVISION, National Institute on Drug 

Abuse (NIDA), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: The purpose of this proposal 

is to inform data requestors about terms 

and conditions for using data generated 

by the Adolescent Brain Cognitive 

Development (SM) (ABCD) Study and the 

Healthy Brain and Child Development 

(HBCD) Study, collectively known as 

the NIH Brain Development Cohorts 

(NBDC), and to obtain signed 

agreements from requestors and their 

institutional officials attesting to their 

commitment to abide by the data use 

terms and conditions. These include 

using data for research purposes; 

adhering to human subjects research 

requirements; not distributing the data 

to non-authorized users; minimizing 

risk of participant identifiability; using 

data ethically and responsibly; and 

keeping the data secure. Recipients 

must include a brief description of their 

research project and submit their signed 

data use agreements to the data 

repository to gain access to NBDC Study 

data. Recipients who plan to conduct 

research studies specifically on 

American Indian/Alaska Native (AI/AN) 

populations must submit an additional 

signed data use certification. 

OMB approval is requested for 3 

years. There are no costs to respondents 


khammond on DSKJM1Z7X2PROD with NOTICES